ThermPix: The Future of Non-Invasive Health Screenings

Our City Hollywood, March 2025 | By Dr. Ariel Soffer

Hollywood is known for its laid-back beaches and sunny weather—but did you know it’s also home to a breakthrough medical innovation? Meet ThermPix®, the handheld infrared thermography (IRT) device revolutionizing how we screen and diagnose many health conditions. This cutting-edge technology was developed locally by Hollywood’s own highly respected vascular surgeon Cardiovascular Specialist Dr. Ariel Soffer, and is now available both here and in 9 countries around the world.

At the Soffer Health Institute, headquartered on Hollywood Boulevard, Dr. Soffer has been pioneering new ways to improve patient care for years. Renowned for his expertise in cardiac and vascular medicine, Dr. Soffer co-founded USA Therm® to tackle a common challenge in healthcare: how to make screenings for chronic venous diseases, like vascular disease, more accurate, non-invasive and without any radiation.

His team recognized a type of infrared thermography as the key. Traditionally, detecting vascular issues often requires multiple visits, sometimes uncomfortable tests, and a host of follow-ups. ThermPix® changes all that by leveraging advanced handheld thermal imaging to quickly identify temperature variations in the body, which can be early indicators of blood flow problems, inflammation, or other issues needing immediate attention.

A Decade in the Making

“It was about a decade ago when I first saw my own leg through a thermal imaging device,” Dr. Soffer recalls. “An esteemed colleague of mine from the United Kingdom, a Vascular Surgeon, was using a device meant for detecting heat signatures through walls on construction sites. When he showed me my leg, through my socks, it just blew my mind. The technology was simply detecting tiny temperature variations in my leg—and in that moment, I knew I had to develop it for human medical needs.”

Fast forward to today, and ThermPix® is changing lives across the globe, catching circulation problems before they become serious, guiding more effective treatments, and allowing patients to understand what’s going on by literally seeing the invisible.

What Makes ThermPix® So Revolutionary?

Completely non-invasive. No one likes the idea of needles or extensive scans. ThermPix® uses infrared technology to capture temperature differences on the skin’s surface—without any contact or radiation. It’s like taking a picture that shows “hot spots” and “cold spots,” which can point to problem areas inside the body.

Read Full Article

amplifAI health partners with USA Therm in a Saudi-US Alliance to Advance Thermographic Applications in Healthcare

Riyadh, Saudi Arabia | September 3, 2024 – amplifAI health is pleased to announce our partnership with USA Therm, a renowned innovator in point-of-care thermal imaging technology. This strategic partnership aims to combine the expertise of both companies to set a new standard in diagnostic capabilities and disease monitoring.

The partnership marks the beginning of a collaboration that merges amplifAI’s advanced AI software with USA Therm’s advanced thermal imaging cameras. By integrating AI-driven diagnostics and thermographic imaging, the partnership is set to improve patient care and operational efficiency, providing healthcare providers with more accurate and actionable insights for early disease detection.

amplifAI health and USA Therm recently showcased their collaborative efforts on stage at the New Cardiovascular Horizons (NCVH) Annual Conference, where they presented their combined product offerings to an audience of leading healthcare professionals, cardiologists, and vascular specialists. The event highlighted the potential impact of this partnership on advancing healthcare imaging and improving patient outcomes.

Dr. Meshari F. Alwashmi, Co-founder and CEO of amplifAI health, shared his thoughts on the partnership:

“Our collaboration with USA Therm represents a significant leap forward in the integration of AI and thermal imaging for healthcare. By combining our expertise, we’re not just enhancing diagnostic accuracy; we’re redefining how early disease detection can be approached.”

Dr. Soffer, Founder and Chairman of the Board of USA Therm, and a Fellow of the American College of Cardiology, added:

“amplifAI health has demonstrated impressive knowledge and creativity that will elevate the entire clinical thermography platform to its rightful place among other established imaging modalities. Their vision of using pattern recognition and AI to enhance human understanding of thermography is truly remarkable.”

About amplifAI Health

amplifAI health is a health tech company focused on transforming early disease detection through AI-driven thermography. With a commitment to innovation and accessibility, amplifAI is making proactive health diagnostics available worldwide.

About USA Therm

USA Therm is an industry leader in point-of-care thermal imaging technology, with FDA-cleared thermal imaging cameras that enhance diagnostic precision and operational efficiency in healthcare. The company is dedicated to advancing thermography as a critical imaging modality in modern medicine.

FDA Approves Cutting-Edge Thermal Imaging Device, Revolutionizing Healthcare and Beyond

FORT LAUDERDALE FL., September 14, 2023 – USA Therm, a leading innovator in the field of medical thermal imaging technology, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted a 510(k) on it’s 2nd generation thermal imaging device.

ThermPix™ leverages cutting-edge thermal imaging technology to provide high-resolution, real-time thermal images of the human body. This non-invasive and non-ionizing imaging device has the potential to transform the way healthcare professionals screen, diagnose and manage a wide range of conditions. The technology allows healthcare providers detect temperature variations, aiding in the screening and early diagnosis of a number of conditions when used adjunctively with other diagnostic modalities

The FDA approval process involved rigorous testing and evaluation, demonstrating the safety and accuracy of ThermPix™. Our team at USA Therm is committed to upholding the highest standards in product development and regulatory compliance, ensuring that healthcare providers and industries can trust the accuracy and reliability of our technology.

“We are thrilled to receive FDA approval for ThermPix™ which represents a significant step forward in the field of thermal imaging technology,” said Eric Heil, Chief Executive Officer of USA Therm, Inc. “We believe that this technology has the potential to revolutionize healthcare by enabling early disease detection and improving patient outcomes. This achievement reflects our dedication to innovation and improving the quality of life for patients worldwide.”

USA Therm is now preparing for the production and distribution of ThermPix™ to healthcare facilities and providers across the United States with the initial focus on peripheral vascular disorders. The company is planning for its commercial launch into the U.S. at the upcoming 2023 UIP World Congress & AVLS 37th Annual Congress September 17 – 21, 2023.

About USA Therm

USA Therm is focused on the development of thermography for use in screening and diagnosing diseases. The proprietary software features AI learning capabilities that have the potential to transform thermography into a standalone diagnostic tool. USA Therm aims to transform diagnostic imaging with easy-to-use and effective products to enable clinicians to make accurate diagnoses and improve patient lives.

USA Therm Receives FDA Clearance for the ThermPix™ Point of Care Infrared Thermography Camera

AVENTURA, FL., May 31, 2022 – USA Therm, a healthcare technology company specializing in the development of AI-assisted infrared thermography diagnostic devices to improve the quality and efficiency of medical imaging, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ThermPix™ Point of Care Infrared Thermography (POCIT) adjunctive diagnostic camera. ThermPix™ is an infrared thermovisual camera with proprietary software that is designed to view, measure, and record heat patterns and variations in the human body for use as adjunctive diagnostic imaging to other diagnostic medical devices.

USA Therm has developed ThermPix™ initially for the adjunctive diagnosis of venous insufficiency, aiming to serve as a quick and convenient tool for identifying thermal patterns when used in combination with ultrasound imaging. ThermPix™ provides clinicians with the ability to quickly screen for heat variations due to its ease of use and portability. Images captured by the camera are uploaded real time to a HIPAA compliant cloud storage platform. The images can then be accessed from a workstation, laptop, tablet, or phone and shared with patients and clinicians.

ThermPix™ addresses key challenges faced in diagnostic imaging, namely the lack of a method to easily identify heat patterns and variations. Currently, the standard of care is duplex ultrasound imaging which requires specialized equipment and expertise. ThermPix™ serves as an easy-to-use, non-contact tool for adjunctive diagnostic imaging for thermally significant indications stemming from heat emitted from the human body.

Dr. Ariel Soffer, the founder of USA Therm said: “We are pleased to receive the FDA 510(k) clearance for ThermPix™ and look forward to entering the U.S. market through partnerships with key opinion leaders in the treatment of venous disease, wound care, and other diseases. ThermPix™ is a portable, infrared thermovisual, non-contact handheld device used to identify relative heat patterns and irregularities suggestive of abnormal veins. Our goal is to ultimately evolve and leverage thermography as a standalone diagnostic tool.”

ThermPix™ thermographic technology is the cornerstone of the company’s product suite, including its AI based predictive diagnostic cloud-based solutions.

About USA Therm

USA Therm is focused on the development of thermography for use in diagnosing diseases. Their proprietary software features AI learning capabilities that have the potential to transform thermography into a standalone diagnostic tool. USA Therm aims to transform diagnostic imaging with easy-to-use and effective products to enable clinicians to make accurate diagnoses and improve patient lives. USA Therm plans to first launch in the venous insufficiency space, later this year.